Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 2
1977 1
1978 2
1981 2
1982 1
1983 4
1984 8
1985 10
1986 9
1987 1
1988 2
1989 3
1990 5
1992 1
1993 5
1994 4
1995 5
1996 2
1997 3
1998 3
1999 4
2000 7
2001 6
2002 4
2003 4
2004 3
2005 1
2006 4
2007 3
2008 5
2009 4
2010 4
2011 4
2012 4
2013 3
2014 6
2015 3
2016 3
2017 3
2018 3
2019 2
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

154 results
Results by year
Filters applied: . Clear all
Page 1
The biology of interleukin-2.
Malek TR. Malek TR. Annu Rev Immunol. 2008;26:453-79. doi: 10.1146/annurev.immunol.26.021607.090357. Annu Rev Immunol. 2008. PMID: 18062768 Review.
Regulatory T cells in the treatment of disease.
Sharabi A, Tsokos MG, Ding Y, Malek TR, Klatzmann D, Tsokos GC. Sharabi A, et al. Among authors: malek tr. Nat Rev Drug Discov. 2018 Nov;17(11):823-844. doi: 10.1038/nrd.2018.148. Epub 2018 Oct 12. Nat Rev Drug Discov. 2018. PMID: 30310234 Review.
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.
Rosenzwajg M, Churlaud G, Mallone R, Six A, Dérian N, Chaara W, Lorenzon R, Long SA, Buckner JH, Afonso G, Pham HP, Hartemann A, Yu A, Pugliese A, Malek TR, Klatzmann D. Rosenzwajg M, et al. Among authors: malek tr. J Autoimmun. 2015 Apr;58:48-58. doi: 10.1016/j.jaut.2015.01.001. Epub 2015 Jan 26. J Autoimmun. 2015. PMID: 25634360 Free article. Clinical Trial.
154 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page